A microbe found in the lower part of the gut that is associated with good health has been comprehensively analyzed and found to have a focused diet breaking down sugars locked away in mucus.
Filament Health Enters Licensing Agreement With Reset Pharma | Psychedelic Invest
Reset Pharma has licensed Filament’s botanical psilocybin drug candidate for a phase 2 clinical trial studying demoralization syndrome Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: